SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)

国家神经疾病和中风研究所(NINDS)正在建立疼痛临床前筛查平台(PSPP)，以响应美国国立卫生研究院(NIH)帮助结束成瘾长期(Hear)倡议。Hear倡议是一项跨NIH的努力，旨在加快成瘾和疼痛领域的基础、翻译和临床研究，以解决国家阿片类药物危机。PSPP的目标是促进阿片类药物替代品的开发，以治疗所有类型的疼痛状况。 这项研究是NIH帮助结束成瘾长期(Hear)倡议的一部分，该倡议旨在加快科学解决方案，以了解疼痛的基础，并加强临床疼痛管理。

"The National Institutes of Neurological Disorders and Stroke (NINDS) is establishing the Preclinical Screening Platform for Pain (PSPP) in response to the National Institutes of Health (NIH) Helping to End Addiction Long-term (HEAL) initiative. The HEAL initiative is a trans-NIH effort to fast track basic, translational, and clinical research in the field of addiction and pain to address the national opioid crisis. The goal of the PSPP is to foster the development of opioid alternatives to treat all types of pain conditions." “This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.”